176 related articles for article (PubMed ID: 6101934)
41. A comparison of once and twice daily atenolol for angina pectoris.
Boyle RM; Bray CL; Naqvi N; Croxson RS; Cruickshank JM
Int J Cardiol; 1983 Apr; 3(1):25-35. PubMed ID: 6343259
[TBL] [Abstract][Full Text] [Related]
42. Haemodynamic dose-response effects of intravenous beta-blocking drugs with different ancillary properties in patients with coronary heart disease.
Taylor SH; Silke B; Lee PS; Hilal A
Eur Heart J; 1982 Dec; 3(6):564-9. PubMed ID: 6130944
[No Abstract] [Full Text] [Related]
43. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
[TBL] [Abstract][Full Text] [Related]
44. Antianginal effects of atenolol and pindolol in patients with stable effort angina pectoris.
Antalóczy Z; Kekes E
Zhongguo Yao Li Xue Bao; 1989 May; 10(3):222-6. PubMed ID: 2609991
[TBL] [Abstract][Full Text] [Related]
45. Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease.
Dagenais GR; Moisan A; Marquis Y; Davies RO; Blouin S
Cardiovasc Res; 1976 Jan; 10(1):25-36. PubMed ID: 1253193
[TBL] [Abstract][Full Text] [Related]
46. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity.
Rodrigues EA; Lahiri A; Hughes LO; Kohli RS; Whittington JR; Raftery EB
Am J Cardiol; 1986 Nov; 58(10):916-21. PubMed ID: 2877564
[TBL] [Abstract][Full Text] [Related]
47. Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Levy JV
Am J Med; 1976 Nov; 61(5):779-89. PubMed ID: 10729
[TBL] [Abstract][Full Text] [Related]
48. A comparison of carvedilol with a combination of propranolol and isosorbide dinitrate in the chronic treatment of stable angina.
Nahrendorf W; Rading A; Steinig G; van der Does R; Schlote A
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S114-6. PubMed ID: 1378136
[TBL] [Abstract][Full Text] [Related]
49. Effect of tolamolol and propranolol on exercise heart rate and angina.
Aronow WS; Spivacek N; Laverty W; Warren M
Clin Pharmacol Ther; 1975 Apr; 17(4):379-84. PubMed ID: 1173059
[TBL] [Abstract][Full Text] [Related]
50. Effect of a twelve-hour hiatus in propranolol therapy on exercise tolerance in patients with angina pectoris.
Bassan MM; Weiler-Ravell D
Am Heart J; 1983 Feb; 105(2):234-8. PubMed ID: 6823805
[TBL] [Abstract][Full Text] [Related]
51. Effect of new beta-adrenergic blocking agent, Atenolol (Tenormin), on pain frequency, trinitrin consumption, and exercise ability.
Roy P; Day L; Sowton E
Br Med J; 1975 Jul; 3(5977):195-7. PubMed ID: 238716
[TBL] [Abstract][Full Text] [Related]
52. Treatment of angina pectoris with metoprolol. A comparison between Durules administered once daily and tablets administered twice daily.
Orö L
Ann Clin Res; 1981; 13 Suppl 30():58-60. PubMed ID: 6794419
[TBL] [Abstract][Full Text] [Related]
53. Comparison of the immediate effects of two beta-blocking drugs: a nonselective and a cardioselective with modest ISA in exercise-induced angina.
Berkenboom GM; Ibrahim T; Abramowicz M; Degre SG
Cardiology; 1987; 74(1):43-8. PubMed ID: 2880663
[TBL] [Abstract][Full Text] [Related]
54. Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris.
Salonen JT; Taskinen E; Salonen R; Seppänen K; Venäläinen J; Rauramaa R
Am J Cardiol; 1986 Nov; 58(12):35E-40E. PubMed ID: 2878600
[TBL] [Abstract][Full Text] [Related]
55. Practolol in treatment of angina pectoris. A double-blind trial.
George CF; Nagle RE; Pentecost BL
Br Med J; 1970 May; 2(5706):402-4. PubMed ID: 4392984
[TBL] [Abstract][Full Text] [Related]
56. A comparison of metoprolol OROS with antenolol in the treatment of effort angina pectoris: a randomized double-blind study.
Floris B; Paoletti G; Pelizza L; Bertulla A; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1991 Apr; 29(4):139-43. PubMed ID: 1906434
[TBL] [Abstract][Full Text] [Related]
57. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
Furberg B; Dahlqvist A; Raak A; Wrege U
Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
[TBL] [Abstract][Full Text] [Related]
58. Lack of rebound during intermittent transdermal treatment with glyceryl trinitrate in patients with stable angina on background beta blocker.
Holdright DR; Katz RJ; Wright CA; Sparrow JL; Sullivan AK; Cunningham AD; Fox KM
Br Heart J; 1993 Mar; 69(3):223-7. PubMed ID: 8096389
[TBL] [Abstract][Full Text] [Related]
59. Double-blind titrated-dose comparison of metoprolol and propranolol in the treatment of angina pectoris.
Frick MH; Luurila O
Ann Clin Res; 1976 Dec; 8(6):385-92. PubMed ID: 795362
[TBL] [Abstract][Full Text] [Related]
60. Double-blind comparison of verapamil and practolol in the treatment of angina pectoris.
Fagher B; Persson S; Svensson SE
Postgrad Med J; 1977 Feb; 53(616):61-5. PubMed ID: 406602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
